NEW YORK (GenomeWeb) – Genedrive announced today that it has signed a distribution agreement with Sysmex Asia Pacific for its Genedrive HCV ID kit and Genedrive PCR platform in the Asia Pacific region.

As part of the agreement, Genedrive retains responsibility for product development, quality management, and manufacturing. Sysmex will be responsible for sales, marketing, customer support, and distribution activities across the region. In addition, Genedrive currently retains the rights over the Indian market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.